The search for the Brown University shooter is over. Last night, the police discovered the body of a man, 48, they believe ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Blood tests for Alzheimer’s disease are becoming more accurate, but researchers stress the need for caution and further study.

Experts predict a test measuring p-tau217 in blood plasma may become a standard screening tool for Alzheimer’s disease in ...

A survey of Alzheimer’s disease prevalence in Norway confirms earlier estimates and might show how education level relates to ...

ALS is a debilitating paralytic disease characterized as the death of upper and lower motor neurons. Fortunately, ALS is ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

Imagine if a simple blood test could offer a glimpse into your future health. Not just whether you have heart disease or ...

ALS is a debilitating paralytic disease characterized by the death of upper and lower motor neurons. Fortunately, ALS is ...

WASHINGTON - With the new year comes new laws for Virginians. Here's what to expect when January 1, 2026 arrives. Under the ...

ENHERTU Plus Pertuzumab Approved in the U.S. for First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer ...